Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-22-013840

Chief Medical Officer sold 8,000 shares at $30.00 ($240,000)

  • Chief Medical Officer acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Garren Hideki Chief Medical Officer 2022-07-06 Option exercise +8,000 $24.90 $199,200 8,000 D: show line 1 in the form
Garren Hideki Chief Medical Officer 2022-07-06 Sale −8,000 $30.00 $240,000 0 D: show line 2 in the form
Open-market sales · 8,000 sh · avg $30.00 · $240,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Garren Hideki Chief Medical Officer 2022-07-06 Option exercise · Stock Option (Right to Buy) −8,000 242,000 D: show line 3 in the form
Loading xslF345X03/doc1.xml…